# Topical Gentamicin and Vancomycin for Vascular Surgical Site Infection Prophylaxis

> **NCT04238923** · PHASE2,PHASE3 · UNKNOWN · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 356 (estimated)

## Conditions studied

- Vascular Diseases
- Peripheral Vascular Disease
- Surgical Site Infection
- Bypass Complication

## Interventions

- **DRUG:** Topical vancomycin paste (1g vancomycin powder + 4mL sterile saline) and Collatamp G gentamicin-eluting sponge (Azralez Pharmaceuticals; 2.0mg gentamicin sulphate/cm2 to cover wound)

## Key facts

- **NCT ID:** NCT04238923
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-01
- **Primary completion:** 2021-05-01
- **Final completion:** 2021-07-01
- **Target enrollment:** 356 (ESTIMATED)
- **Last updated:** 2020-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04238923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04238923, "Topical Gentamicin and Vancomycin for Vascular Surgical Site Infection Prophylaxis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04238923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*